Duke's David Goldstein and colleagues found a SNP associated with people's response to treatment for hepatitis C — the treatment is more successful in European-American than in African-Americans. The SNP, they report in an advance online publication of Nature, is located near interferon-lambda-3.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.